Welcome to our dedicated page for QT Imaging Holdings SEC filings (Ticker: QTIH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The QT Imaging Holdings, Inc. (QTIH) SEC filings page on Stock Titan provides access to the company’s U.S. regulatory disclosures, including current reports, registration statements, and related exhibits. QT Imaging is a medical device company in the healthcare sector that develops and commercializes body imaging systems using low frequency sound waves, and its filings offer detailed insight into its capital structure, financing arrangements, and operational progress.
Investors can review Form 8-K current reports where QT Imaging discloses material events such as private placement (PIPE) financings, warrant repurchases, amendments to credit agreements, and the implementation of a 3:1 reverse stock split of its common stock. Certain 8-K filings also furnish unaudited pro forma condensed consolidated financial statements, which show how transactions like the September 2025 private placement and subsequent debt repayments affect the company’s balance sheet and statements of operations.
The company has filed a Form S-1 registration statement and an amended Form S-1/A, which contain information about its securities, historical financial statements, and various equity and debt instruments, including warrants, convertible notes, bridge loans, and earnout arrangements. These documents, together with other periodic and transactional filings, outline QT Imaging’s status as an emerging growth company and describe key elements of its financing history and customer concentration.
On Stock Titan, these filings are updated in near real time as they are posted to the SEC’s EDGAR system. AI-powered summaries help explain the significance of complex disclosures, highlighting items such as changes to rights of security holders, reverse stock split mechanics, private placement terms, and pro forma adjustments. Users can quickly locate quarterly and annual financial information within registration statements, track capital markets actions, and examine how QT Imaging reports on its imaging business, cloud platform development, and related risks in its official SEC documents.
QT Imaging Holdings, Inc. is registering 29,336,017 shares of common stock for resale by existing securityholders. These shares include 2,562,334 already issued shares and 26,773,683 shares issuable upon exercise of various five-year, ten-year and pre‑funded warrants.
The company will not receive proceeds from resales, but would receive cash if warrants are exercised. As of December 26, 2025, 11,902,198 shares were outstanding, which would rise to 38,667,630 shares if all registered warrants are exercised for cash. The shares stem from prior private placements that raised about $18.9 million and from a senior secured term loan and warrant package with Lynrock Lake totaling $15.1 million in principal.
QT Imaging develops low‑energy sound breast imaging technology, led by its QT Breast Scanner and QTviewer software, and has distribution and manufacturing agreements with Canon-related entities and partners in the U.S. and Saudi Arabia. The prospectus highlights substantial historical losses, significant future capital needs, potential stock overhang from large registered resales, and numerous operational and regulatory risks.
QT Imaging Holdings, Inc. has filed an amended shelf registration to permit the resale of up to 29,336,017 shares of common stock by existing investors. These shares include 2,562,334 shares already issued and additional shares issuable from various five-year, ten-year and pre-funded warrants tied to prior financing transactions.
The company recently effected a 3:1 reverse stock split, approved in August 2025 and effective in October 2025, which adjusted outstanding warrants and share counts. It also entered into a senior secured term loan credit agreement with Lynrock Lake for an aggregate principal amount of $15,100,000, accompanied by a large common stock warrant adjusted to 20,333,623 shares at a $1.20 exercise price after the reverse split.
In 2025 the company completed three private placements raising gross proceeds of approximately $500,000, $200,000 and $18,180,655, issuing common shares and warrants now being registered for resale. QT Imaging will not receive proceeds from investors’ resale of these shares but may receive cash if the registered warrants are exercised. The prospectus also describes exclusive distribution agreements for its QT Breast Scanner in the U.S. and Saudi Arabia and a manufacturing agreement with Canon Medical Systems Corporation.
QT Imaging Holdings, Inc. reported that it has prepared and furnished unaudited pro forma condensed consolidated statements of operations and comprehensive loss for each quarter from December 31, 2024 through September 30, 2025. These pro forma statements show how results would look if certain 2025 financing and debt transactions had been in place starting January 1, 2024.
The pro forma information reflects a September 30, 2025 private placement of securities that closed on October 3, 2025, providing aggregate gross proceeds of about $18,180,655 before offering expenses. It also incorporates the October 6, 2025 repayment to Lynrock Lake Master Fund LP of $5.0 million of long-term debt, plus $360,477 of accrued interest and a Tranche B 2025 premium under an amended credit agreement.
In addition, the pro forma figures remove expenses and losses tied to extinguishment or modification of prior debt repaid in February 2025 and the issuance of the Lynrock Lake term loan, as well as certain non-cash items such as interest expense and changes in the fair value of warrant, derivative, and earnout liabilities.
QT Imaging Holdings, Inc. filed an update providing unaudited pro forma financial information for the nine months ended September 30, 2025. The pro forma statements show how its balance sheet and results would look if a previously completed private placement and a subsequent debt repayment had occurred on January 1, 2025.
The company completed a private placement of securities on September 30, 2025, which closed on October 3, 2025, generating aggregate gross proceeds of about $18,180,655 before offering expenses. The pro forma information also reflects the October 6, 2025 repayment of $5.0 million of long-term debt, plus $360,477 of accrued interest and the Tranche B 2025 Premium, totaling $5,360,477 paid to Lynrock Lake Master Fund LP. These adjustments help illustrate the company’s capital structure and loss profile as if these financing actions had been in place for the full period.
QT Imaging Holdings (QTIH) reported Q3 results showing higher sales but continued losses. Revenue reached $4,192,101 versus $955,970 a year ago, with gross profit of $1,802,673. Operating loss was $1,652,079 and net loss was $4,557,406. For the nine months, revenue was $10,649,930 and net loss totaled $19,694,921.
Cash and restricted cash were $1,735,400 at quarter‑end, while total liabilities were $21,197,385, resulting in a stockholders’ deficit of $9,076,444. The company completed financings including a senior secured term loan (initially $10.1 million, amended to $15.1 million with Tranche B) and an October 2025 private placement providing gross proceeds of $18,180,655 at $4.50 per share. A 3‑for‑1 reverse stock split became effective October 23, 2025. Customer concentration remained high, with Customer A accounting for 99% of Q3 revenue. Management cites minimum order quantities under U.S. and Saudi Arabia distribution agreements as expected support for future cash flows.
QT Imaging Holdings, Inc. furnished an investor presentation under Item 7.01 (Reg FD). On November 10, 2025, the company posted the presentation to its website and furnished it as Exhibit 99.1 to an 8‑K. The information is being furnished, not filed, is not subject to Section 18 liabilities, and is not incorporated by reference into other filings. The company directs readers to Exhibit 99.1 for forward‑looking statements and related risks.
QT Imaging Holdings, Inc. submitted a current report describing that it has released its financial results for the three months ended September 30, 2025. The company announced these quarterly results in a separate press release dated November 10, 2025, which is attached as Exhibit 99.1.
The report specifies that the earnings information in Item 2.02 and Exhibit 99.1 is being furnished to the SEC rather than filed, meaning it is not subject to certain liability provisions and is not automatically incorporated into other registration statements. The filing also notes that the press release includes forward-looking statements and related risk disclosures.
QT Imaging Holdings, Inc. filed a Form S-1 to register up to 29,336,017 shares of common stock for resale by selling securityholders, to be offered from time to time after effectiveness. The registration covers 2,562,334 already-issued shares and 26,773,683 shares issuable upon warrant exercises, including Five Year Common Warrants (24,442,342 shares), Ten Year Common Warrants (523,286 shares), and Pre-Funded Warrants (1,808,055 shares).
The company will not receive proceeds from sales by selling holders; it may receive cash only if warrants are exercised. The filing details a 3:1 reverse stock split effective October 23, 2025. It also outlines financing events: a senior secured term loan with Lynrock Lake totaling $15,100,000 and a related warrant adjusted to 20,333,623 shares at $1.20 post-split, and three private placements with aggregate gross proceeds of approximately $500,000, $200,000, and $18,180,655. The prospectus warns that large potential resales could pressure the stock price.
QT Imaging Holdings, Inc. (QTIH) announced market effectiveness of a 3:1 reverse stock split on October 24, 2025. The company disclosed the update via a press release titled “QT Imaging 3:1 Reverse Stock Split Market Effective on October 24, 2025,” furnished as Exhibit 99.1.
The notice was provided under Item 8.01 (Other Events) in a current report, with the filing signed by Chief Executive Officer Raluca Dinu.